RT Journal Article
SR Electronic
T1 Excess mortality in the general population versus Veterans Healthcare System during the first year of the COVID-19 pandemic in the United States
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.09.13.22279868
DO 10.1101/2022.09.13.22279868
A1 Weinberger, Daniel M.
A1 Rose, Liam
A1 Rentsch, Christopher
A1 Asch, Steven M.
A1 Columbo, Jesse
A1 King, Joseph
A1 Korves, Caroline
A1 Lucas, Brian P.
A1 Taub, Cynthia
A1 Young-Xu, Yinong
A1 Vashi, Anita
A1 Davies, Louise
A1 Justice, Amy C.
YR 2022
UL http://medrxiv.org/content/early/2022/09/14/2022.09.13.22279868.abstract
AB Importance The COVID-19 pandemic had a substantial impact on the overall rate of death in the United States during the first year. It is unclear whether access to comprehensive medical care, such as through the VA healthcare system, altered death rates compared to the US population.Objective Quantify the increase in death rates during the first year of the COVID-19 pandemic in the general US population and among individuals who receive comprehensive medical care through the Department of Veterans Affairs (VA).Design Analysis of changes in all-cause death rates by quarter, stratified by age, sex race/ethnicity, and region, based on individual-level data. Hierarchical regression models were fit in a Bayesian setting. Standardized rates were used for comparison between populations.Setting and participants General population of the United States, enrollees in the VA, and active users of VA healthcare.Exposure and main outcome Changes in rates of death from any cause during the COVID-19 pandemic in 2020 compared to previous years.Results Sharp increases were apparent across all of the adult age groups (25 years and older) in both the general US population and the VA populations. Across all of 2020, the relative increase in death rates was similar in the general US population (RR: 1.20 (95% CI: 1.17, 1.22)), VA enrollees (RR: 1.20 (95% CI: 1.14, 1.29)), and VA active users (RR: 1.19 (95% CI: 1.14, 1.26)). Because the pre-pandemic standardized mortality rates were higher in the VA populations prior to the pandemic, the absolute rates of excess mortality were higher in the VA populations.Conclusions and Relevance Despite access to comprehensive medical care, active users of the VA had similar relative mortality increases from all causes compared with the general US population. Factors that influenced baseline rates of death and that mitigated viral transmission in the community are more likely to have influenced the impact of the pandemic.Competing Interest StatementDMW has received consulting fees for work unrelated to this manuscript from Pfizer, Merck, GSK, Affinivax, and Matrivax, and is Principal Investigator on research grants from Pfizer and Merck to Yale University for work unrelated to this manuscript. CK has been an investigator on projects with research grants from Pfizer and Sanofi Pasteur for work unrelated to this manuscript. The other authors declare no conflicts.Funding StatementThis material is based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB at Yale School of medician waived ethical approval for the analysis of the NCHS data. The IRB at Stanford University and the IRBs at the West Haven VA, Palo Alto VA, and White River Junction VA gave ethical approval for the analysis of the VA data.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode used for all analyses can be found at https://github.com/VA-CareDisruptions/VA_CDC_death_comparison. Data on US mortality, with the exception of state/region, can be obtained from https://www.cdc.gov/nchs/nvss/mortality_public_use_data.htm. For additional variables, including geography, a data use agreement with NCHS is required. VA data and the analytic data sets used for this study can be made available to researchers with a VA IRB approved study protocol and data use agreement. Information is available at https://www.virec.research.va.gov or contact the VA Information Resource Center at VIReC{at}va.gov. https://github.com/VA-CareDisruptions/VA_CDC_death_comparison